Intriguingly, FTO, ALKBH5 and METTL14, known for their opposing roles in m6A catalysis, exhibited significant downregulation in HCC compared to the corresponding adjacent non-tumorous tissues (Fig. 2a). This evidence concerns the gene ALKBH5 and hepatocellular carcinoma.